TFC BioSciences, Inc. is a leading developer and manufacturer of liposome-based fluorescence detection systems, known as Fluorosomes, for use in drug discovery and related fields. Their innovative technology, including the flagship product Fluorosome trans-pgp assay, allows for the characterization of P-glycoprotein drug interactions, providing valuable insights into drug absorption and resistance mechanisms.
With a focus on continuous improvement through innovation, TFC BioSciences offers specific, low sample requirement assays that are cost-effective and convenient, providing real-time kinetic measurements and full analysis in a fluorescence microplate reader. Their advanced technology and expertise make them a trusted partner in the field of drug discovery and ADMET studies.
Generated from the website